drugset / Trial / NCT03977792
An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis
RandomizedParallel-groupOpen-labelTreatment
Summary
BOR15001L7 is a natural product. The primary objective of this study is to demonstrate its non-inferiority to docosanol 10% based on the healing time of cold sores in patients with recurrent herpes labialis.
Timeline
- Start
- 2020-09
- Primary completion
- 2021-07
- Completion
- 2022-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BOR15001L7 | Other / unclassified | — | Topical |
| Comparator | Docosanol | Small molecule | 10 % | Topical |